Read next
Dr. Mike McCune, head of the foundation’s HIV Frontiers Program, details a groundbreaking new partnership with Novartis to develop affordable, single-dose gene therapies for people infected with sickle cell disease and HIV.
CEO Mark Suzman makes the case for immediate global action on climate change, including investments in research and innovation and stronger social safety nets.
Rodger Voorhies, president of the foundation’s Global Growth & Opportunity Division, discusses efforts to help farmers adapt to climate change in countries that are already being affected by rising temperatures.
Get the Optimist newsletter
Join 300,000 readers who see the world differently. Subscribe for hopeful stories about the people and partnerships improving lives around the world — every other week.